Form D Explorer

Source evidence

BioIntelliSense, Inc. · 0001824134-26-000001

D/A filed June 4, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
GOLDEN
street1
17301 W. COLFAX AVENUE
street2
SUITE 152
zipCode
80401
entityName
BioIntelliSense, Inc.
entityType
Corporation
stateOrCountry
Colorado
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold58349365number58349365/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount58350027number58350027/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count14number14/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 09e5d4564d572521a393b76f659924d4b111897c09183f3b2d8696f4cd111871. This proves extraction identity, not the accuracy of the filer's claims.